Lymphatic filariasis

Lymphatic filariasis is a neglected tropical disease caused by parasitic filarial worms that live in the human lymphatic system and are transmitted by mosquitoes. Long-term infection can cause lymphoedema (painful swelling of the limbs), its most severe form elephantiasis, and hydrocele (swelling of the scrotum). It is one of the world's leading causes of permanent disability.

Lymphatic filariasis is also one of the great elimination campaigns in public health. According to the World Health Organization, more than 650 million people in 39 countries still required preventive treatment as of late 2024, while more than 870 million people in areas that once needed it no longer do.

Three species of nematode worms cause the disease:

• Wuchereria bancrofti, responsible for about 90% of cases, found across Africa, Asia, the Pacific, and parts of the Americas.
• Brugia malayi, found in South and Southeast Asia.
• Brugia timori, restricted to parts of Indonesia and Timor-Leste.

Adult worms are thread-like, up to about 10 cm long, and can live for 6–8 years in the lymphatic vessels. Mating females release millions of microscopic larvae called microfilariae into the blood. In many regions these circulate mostly at night (nocturnal periodicity), matching the biting times of the local mosquito vectors.

The parasite needs both humans and mosquitoes to complete its life cycle:

1. A mosquito takes up microfilariae while feeding on an infected person.
2. Inside the mosquito, the larvae develop over roughly 10–14 days into infective third-stage larvae, which migrate to the mosquito's mouthparts.
3. When the mosquito bites again, the larvae enter the skin near the bite wound and travel to the lymphatic system, where they mature into adults over several months.

The parasites do not multiply in the mosquito, so infection builds up only through repeated bites over months or years. That is why the disease concentrates in communities with long-term, intense exposure rather than in short-term travelers.

Several mosquito genera act as vectors, depending on the region:

• Culex mosquitoes, especially Culex quinquefasciatus of the Culex pipiens complex, transmit W. bancrofti in urban and peri-urban areas.
• Anopheles mosquitoes, the same genus that transmits malaria, are the main vectors in rural Africa.
• Aedes mosquitoes transmit the parasite in parts of the Pacific islands.
• Mansonia mosquitoes transmit Brugia species in parts of Asia.

Most infected people show no obvious symptoms for years, although the worms are already damaging the lymphatic vessels. As lymph drainage fails, fluid accumulates in the tissues. Repeated bacterial skin infections in the affected limbs, called acute attacks, drive the swelling further. In advanced lymphoedema the skin thickens and hardens into elephantiasis.

Beyond pain and disability, the disease carries heavy social stigma and economic loss, and it often affects mental health. Simple hygiene-based care (washing, skin care, elevation and exercise of affected limbs) reduces acute attacks and progression. Hydrocele can be corrected surgically.

In 2000 the WHO launched the Global Programme to Eliminate Lymphatic Filariasis, built on two pillars:

• Stopping transmission through mass drug administration: entire at-risk communities receive annual single doses of safe drug combinations, usually albendazole with either diethylcarbamazine (DEC) or ivermectin, for at least five years. Since 2017 the WHO has also recommended a triple-drug regimen (ivermectin, DEC, and albendazole) in suitable settings, which clears microfilariae more completely after a single round.
• Alleviating suffering through morbidity management and disability prevention for people already affected.

Drug donations from pharmaceutical companies have supported billions of treatments. Vector control, including insecticide-treated nets also used against malaria, adds further protection.

A growing number of countries have been validated by the WHO as having eliminated lymphatic filariasis as a public health problem, including Sri Lanka, Togo, Egypt, Malawi, Bangladesh, and Lao PDR. Validation requires showing that infection has fallen below transmission thresholds and that care is available for people living with the disease.

Lymphatic filariasis belongs to the wider family of mosquito-borne disease. Its control relies on the same tools of epidemiology and vector biology used against malaria, dengue fever, and West Nile fever. Research into Wolbachia is directly relevant: filarial worms depend on their own Wolbachia symbionts, so antibiotics such as doxycycline that kill the bacteria also sterilize and slowly kill the adult worms.